You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 2.2% | 2.5% |
| Div Cover | 1.2 | 2.3 |
| Op Mrgn | 21.6% | 34.7% |
| ROCE | 39.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | 38.0 | 1,689.5 |
| PEG | 0.2 | 0.1 |
| Price / Revenue | 5.4 | 4.9 |
| Price / Book value | 8.5 |
| Latest | Forecast | |
|---|---|---|
| Revenue | 5.4% | 5.1% |
| PBT | 33.4% | n/a |
| EPS | 165.9% | 8.6% |
| DPS | 5.3% | -0.3% |
| Year Ending | Revenue ($m) |
Pre-tax ($m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2014-12-31 | 42,237.00 | 17,283.00 | $4.12 | 13.8 | 0.1 | 177% | $1.77 | 3.1% |
| 2015-12-31 | 39,498.00 | 5,401.00 | $1.58 | 33.4 | -0.5 | -62% | $1.81 | 3.4% |
| 2016-12-31 | 39,807.00 | 4,659.00 | €1.42 | 39.4 | -88.6 | 0% | €1.85 | 3.3% |
| 2017-12-31 | 40,122.00 | 6,521.00 | $0.88 | 63.9 | -1.5 | -44% | $1.89 | 3.4% |
| 2018-12-31 | 42,294.00 | 8,701.00 | $2.34 | 32.2 | 0.2 | 166% | $1.99 | 2.6% |
| Year Ending | Revenue ($m) |
Pre-tax ($m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2019-12-31 | 46,776.98 | 16,233.04 | $5.16 | 1,689.5 | 14.0 | 120% | $2.21 | 253.8% |
| 2020-12-31 | 49,432.50 | 17,639.64 | $5.63 | 1,557.4 | 168.3 | 9% | $2.38 | 273.5% |
| Merck to buy Tilos Therapeutics for up to $773m Sharecast News | 10 Jun |
|---|---|
| Peloton scraps IPO in favour of $1bn tie up with Merck Sharecast News | 21 May |
| Merck to buy Antelliq Group for EUR2.1bn Sharecast News | 14 Dec |